Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Net Sales
276.39
230.12
176.59
136.89
Other Operating Income
0.00
0.00
0.00
0.00
Total Operating income
276.39
230.12
176.59
136.89
Raw Material Cost
22.87
15.46
11.08
13.88
Purchase of Finished goods
113.60
94.98
72.42
54.94
(Increase) / Decrease In Stocks
-2.78
-2.82
-2.64
-4.10
Employee Cost
44.20
38.86
35.42
25.49
Power Cost
0.00
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
-0.01
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
Other Expenses
45.95
42.31
33.93
37.31
Total Expenditure (Excl Depreciation)
223.83
188.79
150.20
127.51
Operating Profit (PBDIT) excl Other Income
52.56
41.33
26.39
9.38
Other Income
4.28
2.05
1.22
0.14
Operating Profit (PBDIT)
56.84
43.38
27.61
9.52
Interest
5.88
4.58
2.75
2.42
Exceptional Items
-2.92
0.00
0.00
0.00
Gross Profit (PBDT)
48.04
38.80
24.86
7.10
Depreciation
9.78
6.74
3.40
2.09
Profit Before Tax
38.27
32.07
21.46
5.01
Tax
9.71
8.55
5.10
1.42
Provisions and contingencies
0.00
0.00
0.00
0.00
Profit After Tax
28.55
23.52
16.36
3.59
Extraordinary Items
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
28.55
23.52
16.36
3.59
Share in Profit of Associates
-1.50
0.00
0.00
-0.22
Minority Interest
0.00
-1.34
-0.08
0.00
Other related items
0.00
0.00
0.00
0.00
Consolidated Net Profit
27.06
22.17
16.28
3.37
Equity Capital
24.45
24.45
20.00
20.00
Face Value
10.0
10.0
10.0
10.0
Reserves
145.43
98.15
21.16
7.30
Earnings per share (EPS)
11.07
9.07
8.14
1.69
Diluted Earnings per share
10.76
10.78
8.14
1.68
Operating Profit Margin (Excl OI)
19.02%
17.96%
14.94%
6.85%
Gross Profit Margin
17.38%
16.86%
14.08%
5.19%
PAT Margin
10.33%
10.22%
9.26%
2.62%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 20.11% vs 30.31% in Mar 2025
Consolidate Net Profit
YoY Growth in year ended Mar 2026 is 22.06% vs 36.18% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 27.17% vs 56.61% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 28.38% vs 66.55% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has improved from Mar 2025
Compare Annual Results Of Chandan Healthca With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
276.39
99.07
177.32
178.98%
Other Operating Income
0.00
0.00
0.00
Total Operating income
276.39
99.07
177.32
178.98%
Raw Material Cost
22.87
0.00
22.87
Purchase of Finished goods
113.60
21.14
92.46
437.37%
(Increase) / Decrease In Stocks
-2.78
-0.22
-2.56
-1,163.64%
Employee Cost
44.20
14.33
29.87
208.44%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
45.95
27.10
18.85
69.56%
Total Expenditure (Excl Depreciation)
223.83
62.35
161.48
258.99%
Operating Profit (PBDIT) excl Other Income
52.56
36.72
15.84
43.14%
Other Income
4.28
2.72
1.56
57.35%
Operating Profit (PBDIT)
56.84
39.44
17.40
44.12%
Interest
5.88
3.15
2.73
86.67%
Exceptional Items
-2.92
0.00
-2.92
Gross Profit (PBDT)
48.04
36.29
11.75
32.38%
Depreciation
9.78
5.95
3.83
64.37%
Profit Before Tax
38.27
30.34
7.93
26.14%
Tax
9.71
3.21
6.50
202.49%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
28.55
27.13
1.42
5.23%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
28.55
27.13
1.42
5.23%
Share in Profit of Associates
-1.50
-0.02
-1.48
-7,400.00%
Minority Interest
0.00
-12.98
12.98
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
27.06
14.13
12.93
91.51%
Equity Capital
24.45
15.40
9.05
58.77%
Face Value
10.00
10.00
0.00
Reserves
145.43
85.96
59.47
69.18%
Earnings per share (EPS)
11.07
9.18
1.89
20.59%
Diluted Earnings per share
10.76
9.83
0.93
9.46%
Operating Profit Margin (Excl OI)
19.02%
37.06%
0.00
-18.04%
Gross Profit Margin
17.38%
36.63%
0.00
-19.25%
PAT Margin
10.33%
27.38%
0.00
-17.05%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 276.39 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 20.11% vs 30.31% in Mar 2025
Annual - Consolidate Net Profit
Consolidate Net Profit 27.06 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 22.06% vs 36.18% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 52.56 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 27.17% vs 56.61% in Mar 2025
Annual - Interest
Interest 5.88 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 28.38% vs 66.55% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.02%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has improved from Mar 2025






